Skip to NavigationSkip to content

News

Japanese company Taisho Pharmaceuticals has offered Bristol-Myers Squibb $1.6 billion for its UPSA consumer health business.
UK drug watchdog NICE has revealed that it has recommended Eisai’s Lenvima (lenvatinib) for use on the NHS in England and Wales as a life-extending...
AstraZeneca has announced that its partner Fibrogen has secured the first national approval for its hypoxia-inducible factor prolyl hydroxylase...
Indian authorities have seized samples of Johnson & Johnson’s Baby Powder from a factory in Baddi in Northern India, after Reuter’s revealed...
American multinational Pfizer and British firm GlaxoSmithKline are set to combine their consumer healthcare units in a venture worth billions.
Shares in Canadian cannabis company Tilray jumped by more than 11% today after the British Columbia-based firm announced its entry into a global...
Private consultancy firms were paid at least £26 million as part of a reorganisation of the NHS, in what has been described as an “unacceptable”...
Israeli and South Korean-based drug makers Teva and Celltrion are set to move in on the market share occupied by Roche and Genentech’s Herceptin (...
A study has found that Eli Lilly’s Taltz (ixekizumab) met the primary and all secondary endpoints in patients with active psoriatic arthritis (PsA...
New Jersey-based pharma firm Johnson & Johnson plans to buy back $5 billion in shares after news agency Reuters released an investigation which...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches